|
DR.
POLASCIK'S PUBLICATIONS
Comparison
of laparoscopic and open retropubic urethropexy for
treatment of stress urinary incontinence.
Polascik TJ, Moore RG, Rosenberg MT and Kavoussi LR:
Urology 45: 647, 1995.
Radical
retropubic prostatectomy the influence of accessory
pudendal arteries on the recovery of sexual function.
Polascik TJ and Walsh PC: J Urol 153: 150, 1995.
Radical
prostatectomy in men less than 50 years old.
Riopel MA, Polascik TJ, Partin AW, Sauvageot J, Walsh
PC, and Epstein JI: Urol Oncol 1 80, 1995.
Novel
suppressor loci on chromosome 14q in primary bladder
cancer.
Chang WYH, Cairns P, Schoenberg MP, Polascik TJ and
Sidransky D: Cancer Research 55: 3246, 1995.
Distinct
regions of allelic loss on chromosome 4 in human primary
bladder carcinoma.
Polascik TJ, Cairns P, Chang WYK, Schoenberg MP and
Sidransky D: Cancer Research 55: 5396, 1995.
High
frequency of homozygous deletion at p16/CDKN2 in primary
human tumors.
Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J,
Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter
JL, Buckler A, Gabrielson E, Tockman M, Cho K, Hedrick
L, Bova GS, Isaacs W, Koch W, Schwab D and Sidransky
D: Nature Genetics 11: 210, 1995.
Partial
nephrectomy technique, complications and pathological
findings.
Polascik TJ, Pound CR, Meng MV, Partin AW and Marshall
FF: J Urol 154: 1312, 1995.
Intraoperative
sonography for the evaluation and management of renal
tumors experience with 100 patients.
Polascik TJ, Meng MV, Epstein JI and Marshall FF:
J Urol 154: 1676, 1995.
Reappraisal
of the role of human chorionic gonadotropin in the
diagnosis and treatment of the nonpalpable testis:
A 10-year experience.
Polascik TJ, Chan-Tack KM, Jeffs RD and Gearhart JP:
J Urol 156: 804, 1996.
Distal
nephron renal tumors: microsatellite allelotype.
Polascik TJ, Cairns P, Epstein JI, Fuzesi L, Ro JY,
Marshall FF, Sidransky D and Schoenberg MP: Cancer
Research 56: 1892, 1996.
High-density
mapping of chromosomal arm 1q in renal collecting
duct carcinoma region of minimal deletion at 1q32.1-32.2.
Steiner G, Cairns P, Polascik TJ, Marshall FF, Epstein
JI, Sidransky D and Schoenberg M: Cancer Research
56: 5044, 1996.
Intraoperative sonographic evaluation of the
kidney.
Polascik TJ and Marshall FF: AUA Update Series, Vol.
XVI, No. 18, 1997.
Multivariate
models as predictors of pathological stage using Gleason
score, clinical stage and serum prostate-specific
antigen.
Polascik TJ, Pearson JD and Partin AW: Seminars in
Urologic Oncology 16 :160-171, 1998.
Laparoscopic
ureteroureterostomy for retrocaval ureter.
Polascik TJ and Chen R: J Urol 160 :121, 1998.
Frequent
occurrence of metastatic disease in patients with
renal cell carcinoma and intrahepatic or supradiaphragmatic
intracaval extension treated with surgery: an outcome
analysis.
Polascik TJ, Partin AW, Pound CR and Marshall FF:
Urology 52 :995-999, 1998.
Prostate-specific
antigen 1998: What we have learned and where we are
going. Part I Clinical utility of PSA for the detection
of prostate cancer.
Polascik TJ, Oesterling, JE and Partin AW: AUA Update
Series, Vol. 17, No. 27, 1998.
Prostate-specific
antigen 1998: What we have learned and where we are
going. Part II Detection, staging and monitoring of
prostate cancer.
Polascik TJ, Oesterling, JE and Partin AW: AUA Update
Series, Vol. 17, No. 28, 1998.
Multivariate analysis: Predicting pathologic
stage of prostate cancer with PSA.
Polascik TJ and Partin AW: Contemporary Urology 10:76-79,1998.
Comparison of radical prostatectomy and 125I
interstitial radiotherapy for the treatment of clinically
localized prostate cancer: A 7-year biochemical (PSA)
progression analysis.
Polascik TJ, Pound CR, DeWeese TL and Walsh PC: Urology
51: 884, 1998.
Use of multivariate models to improve prediction
of pathologic stage for men with clinically localized
prostate cancer.
Polascik TJ, Pearson JD and Partin AW: Prostate Cancer
and Prostatic Diseases 5:1-6, 1998.
Prostate-specific antigen: A decade of discovery
- What we have learned and where we are going.
Polascik TJ, Oesterling JE and Partin AW: J Urol 162:293-306,
1999.
Comparison of clinical staging algorithms and
111Indium-capromab pendetide immunoscintigraphy in
the prediction of lymph node involvement in high-risk
prostate carcinoma patients.
Polascik TJ, Manyak MJ, Haseman M, Gurganus RT, Rogers
B, Maguire RT and Partin AW: Cancer 85: 1586-1592,
1999.
Ablation of renal tumors in a rabbit model with
interstitial saline augmented radiofrequency energy:
Preliminary report of a new technology.
Polascik TJ, Hamper U, Lee BR, Dai Y, Hilton J, Magee
CA, Crone JK, Shue MJ, Ferrell M, Adiletta M and Partin
AW: Urology 53: 465-472, 1999.
Influence of sextant prostate needle biopsy
or surgery on the detection and harvest of intact
circulating prostate cancer cells.
Polascik TJ, Wang ZP, Shue M, Di S, Gurganus R, Hortopan
S, Ts'O POP and Partin AW: J Urol 162: 749-52, 1999.
Capromab pendetide imaging of prostate cancer.
Haseman MK, Rosenthal SA and Polascik TJ: Cancer Biotherapy
and Radiopharmaceuticals, 15: 131-140, 2000.
Survey of neuromuscular injuries to the patient
and surgeon during urologic laparoscopic surgery.
Wolf JS, Marcovich R, Gill IS, Sung GT, Kavoussi LR,
Clayman RV, McDougall EM, Shalhav A, Dunn MD, Afane
JS, Moore RG, Parra RO, Winfield HN, Sosa RE, Chen
RN, Moran ME, Nakada SY, Hamilton BD, Albala DM, Koleski
F, Das S, Adams JB and Polascik TJ: Urology 55: 831-6,
2000.
Advances in DVT prophylaxis in Urology.
Raj G, Subramanian SV and Polascik TJ: Contemporary
Urology 12 (9): 56, 2000.
HIV
infection presenting as an unusually large pure yolk
sac tumor of the testis.
Munver R, Donehower RC, Kronz JD and Polascik TJ:
J Urol 164: 1653-54, 2000.
Synthesis
and evaluation of 18F-labeled choline as an oncologic
tracer for positron emission tomography
initial findings in prostate cancer.
DeGrado TR, Coleman RE, Wang S, Baldwin SW, Orr MD,
Robertson CN, Polascik TJ and Price DT:
Cancer Research 61:110-117, 2001.
Management of small renal tumors: an overview.
Reddan DN, Raj GV and Polascik TJ: Am J Med 110:558-562,
2001.
Utility of capromab pendetide (ProstaScint)
imaging in the management of prostate cancer.
Rosenthal SA, Haseman MK and Polascik TJ: Techniques
in Urology 7:27-37, 2001.
Partial nephrectomy for renal tumors.
Polascik TJ and Marshall FF: AUA Update Series, Vol.
20, No. 21, 2001.
Pilot
study of dietary fat restriction and flaxseed supplementation
in men with prostate cancer before surgery: Exploring
the effects on hormonal levels, prostate-specific
antigen, and histopathologic features.
Demark-Wahnefried W, Price DT, Polascik TJ, Robertson
CN, Anderson EE, Paulson DF, Walther PJ, Gannon M
and Vollmer RT: Urology 58: 47-52, 2001.
Clinical utility of 111In-Capromab pendetide
immunoscintigraphy in the detection of early recurrent
prostate cancer after radical prostatectomy.
Raj GV, Partin AW and Polascik TJ: Cancer 94: 987-996,
2002.
Comparison of [18F] Fluorocholine and [18F]
Fluorodeoxyglucose for positron emission tomography
of androgen dependent and androgen independent prostate
cancer.
Price DT, Coleman RE, Liao RP, Robertson CN, Polascik
TJ and DeGrado TR: J Urology 168: 273-280, 2002.
Hypertonic saline-augmented radiofrequency ablation
of the VX-2 tumor implanted in the rabbit kidney:
A short-term survival pilot study.
Munver R, Threatt CB, Delvecchio FC, Preminger GM
and Polascik TJ: Urology 60: 170-175, 2002.
Molecular genetics and histopathologic features
of adult distal nephron tumors.
Polascik TJ, Bostwick DG and Cairns P: Urology 60:
941-946, 2002.
Management of the small renal tumor with radiofrequency
ablation.
Raj GV, Reddan DJ, Hoey MB, and Polascik TJ: Urology
61:23-29, 2003.
Autoimmune testicular vasculitis.
Raj GV, Ellington KS, and Polascik TJ: Urology 61:
1035, 2003.
Use of bipolar laparoscopic forceps to occlude
and transect the retroperitoneal vasculature: A porcine
model.
Santa-Cruz RW, Auge BK, Lallas CD, Preminger GM and
Polascik TJ: J Endourology 17 (3): 181-5, 2003.
An exploratory study of the effects of a low-fat,
flaxseed -supplemented diet on proliferation of benign
prostatic epithelium and prostate-specific antigen.
Demark-Wahnefried W, Robertson CN, Walther PJ, Polascik
TJ, Paulson DF, and Vollmer RT: Urology 63: 900-904,
2004.
Promoter hypermethylation profile of kidney
cancer.
Dulaimi E, Ibanez de Caceres I, Uzzo RG, Al-Saleem
T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE
and Cairns P: Clin Can Res 10: 3972-79, 2004.
Does prior benign prostate biopsy predict outcome
for patients treated with radical perineal prostatectomy?
Raj GV, Brashears JH, Anand A, Paulson DF and Polascik
TJ: Urology 2005 173(6): 2160-5.
Renal cryoablation and radiofrequency ablation:
an evaluation of worst case scenarios in a porcine
model.
Brashears JH, Raj GV, Crissi A, Young MD, Dylewski
D, Nelson R, Madden JF and Polascik TJ: Journal of
Urology 173: 2160-65, 2005.
ProstaScintTM (Capromab Pendetide) Imaging Technique
Using a Hybrid Gamma-CT Camera.
Wong TZ, Turkington TG, Polascik TJ, and Coleman RE:
AJR 2005: 184: 676-80.
Ovarian hyperstimulation causing ureteral obstruction
in the gravid female.
Wiygul JB, Lallas C, Silverstein A, and Polascik TJ:
(in press Urology 2005).
Supplement use among men with prostate cancer.
Wiygul JB, Evans BR, Peterson BL, Polascik TJ, Walther
PJ, Robertson CN, Albala DM, and Demark-Wahnefried
W: Urology 66:161-66, 2005.
An open-label trial evaluating the safety and
efficacy of zoledronic acid in preventing bone loss
in hormone-sensitive prostate cancer patients with
bone metastases.
Polascik TJ, Given RW, Metzger C, Julian SR, Vestal
JC, Karlin GS, Barkley CS, Bilhartz DL, Lacerna LV,
Petrone SE and McWhorter LT: (in press, Urology November
2005).
Complications following percutaneous radiofrequency
ablation of renal tumors.
Weizer A, Raj GV, Nelson R, Robertson C and Polascik
TJ: (in press Urology December 2005).
Salvage Prostate Cryoablation after primary
Interstitial Brachytherapy Failure: a feasible approach.
Mouraviev V, Evans B , and Polascik TJ: In Prostate
Cancer and Prostatic Diseases (in press 2005).
The effect of freeze time during renal cryoablation:
a swine model.
Auge BK, Santa-Cruz RW, Polascik TJ: (submitted, J
Endourology 2005).
Rectourethral fistula after combination radiotherapy
for prostate cancer.
Marguet C, Raj GV, Brashears JH, Anscher MS, Ludwig
K, Polascik TJ and Robertson CN: (submitted Urology
2005).
Utility of a novel ultrasound contrast agent
in real-time imaging of renal ablative lesions in
a porcine model.
Brashears JH, Raj GV, Nelson RA and Polascik TJ
Treatment of bilateral interpolar renal cell
carcinoma with minimally invasive ablative approaches.
Marguet CG, Brashears JH, Raj GV, Nelson R, and Polascik
TJ: (submitted Urology 2005).
^
Back to top
|
